Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.

We compared microRNA profiles between choriocarcinoma and non-cancerous trophoblasts, and revealed that miR-199b was underexpressed in choriocarcinoma. By computational prediction and microarray studies, SET (protein phosphatase 2A inhibitor) was shown to be one of the target genes regulated by miR-199b. Ectopic expression of miR-199b inhibited endogenous SET protein levels and the activity of the luciferase reporter containing the 3'-UTR of SET. Further comparisons of formalin-fixed paraffin-embedded human choriocarcinoma, mole, and non-cancer trophoblast tissues confirmed the initial findings of low miR-199b expression and SET upregulation in choriocarcinomas, suggesting that microRNA-dysregulated SET protein may account for the rapid growth seen with choriocarcinomas.

[1]  B. Ballermann,et al.  Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor. , 1998, Journal of the American Society of Nephrology : JASN.

[2]  Stephen R. Master,et al.  Differential Expression of miRNAs in Papillary Thyroid Carcinoma Compared to Multinodular Goiter Using Formalin Fixed Paraffin Embedded Tissues , 2007, Endocrine pathology.

[3]  D. Repsilber,et al.  Unlocking pathology archives for microRNA-profiling. , 2008, Anticancer research.

[4]  P. Disaia,et al.  Clinical Gynecologic Oncology , 1981 .

[5]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[6]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[7]  J. Soper.  Gestational trophoblastic disease. , 2006, Obstetrics and gynecology.

[8]  M. Mumby,et al.  The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation , 1993, Cell.

[9]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  I. Shih.  Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets. , 2007, The Lancet. Oncology.

[12]  R. Ach,et al.  Direct and sensitive miRNA profiling from low-input total RNA. , 2006, RNA.

[13]  J. Baeten,et al.  High‐throughput microRNAome analysis in human germ cell tumours , 2007, The Journal of pathology.

[14]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[15]  E. Labourier,et al.  Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. , 2008, The Journal of molecular diagnostics : JMD.

[16]  M. Monden,et al.  Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. , 1999, Nucleic acids research.

[17]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[18]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[19]  N. Tanuma,et al.  Up-regulation of I-2(PP2A)/SET gene expression in rat primary hepatomas and regenerating livers. , 2000, Cancer letters.

[20]  R. Berkowitz,et al.  Gestational trophoblastic disease , 1995, Cancer.

[21]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Tzu-Hao Wang,et al.  Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression , 2006, International journal of cancer.

[23]  Jason H. Moore,et al.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.

[24]  W. Kung,et al.  Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways , 2006, Oncogene.